Sarcoidosis Withdrawn Phase 2 Trials for Adalimumab (DB00051)

Also known as: Sarcoid / Sarcoidosis, unspecified / Sarcoidosis (disorder) / Boeck's disease / Besnier-Boeck-Schaumann's disease / Schaumann's disease / Sarcoidosis NOS

IndicationStatusPhase
DBCOND0013300 (Sarcoidosis)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00731757Efficacy Study of Humira in the Treatment of Cutaneous SarcoidosisTreatment
NCT00690911Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous SarcoidosisTreatment